Patients with certain malignancies or other disorders may benefit from a bone marrow transplant (BMT). A bone marrow transplant involves extracting cells from the donor's bone marrow (stem cells), screening them, and returning them to the donor (patient) or another person. After a person's own unhealthy bone marrow has been treated to eliminate the aberrant cells, BMT is used to transfuse healthy bone marrow cells into him or her. Since 1968, bone marrow transplantation has been used to treat diseases such leukemias, lymphomas, aplastic anaemia, immune deficiency syndromes, and various solid tumour malignancies.
Hematopoietic stem cell transplantation (HSCT) is an intravenous infusion of hematopoietic stem cells used to restore blood cell production in individuals with damaged or dysfunctional bone marrow or immune systems. This approach has been utilised to treat a variety of malignant and nonmalignant disorders with increasing frequency during the last half-century.
Title : Phlebotomy therapy in Sickle cell disease of double heterozygosity HbSC and rare congenital erythrocytosis in hemoglobin variants
Epifania Rita Testa, S Maria degli Angeli Hospital, Italy
Title : The utility of SYNTAX score predictability by electrocardiogram parameters in patients with unstable angina
Hamed Bazrafshan, Shiraz University of Medical Sciences, Iran (Islamic Republic of)
Title : Safety of not withholding Clopidogrel Therapy during the immediate several days pre and post Trans-Urethral Resection of Prostate (TURP) A retrospective cohort study
Ahmed Kamel Abdulhamid, University of Kerbala, Iraq
Title : The contested market of plasma
Jean Mercier Ythier, University of Paris-Panthéon-Assas, France
Title : Muscle Strength and Quality of life in children with Sickle Cell Anemia
Noha Hassan Mahboub, Cairo University, Egypt